Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Does CBD Increase Neurotrophic Factors Like BDNF In Mood Disorder Patients? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

Research into CBD and BDNF links has gained momentum as scientists explore whether cannabidiol can influence brain plasticity. Brain-derived neurotrophic factor (BDNF) plays a vital role in supporting neuronal growth and resilience, both of which are often impaired in mood disorders. For patients with a mental health condition, the possibility that CBD could enhance BDNF levels offers hope for treatments that go beyond symptom relief to target underlying brain mechanisms. 

While early findings are promising, much of the evidence still comes from animal models or small human studies, so further trials are needed to confirm consistent benefits. 

Can I use Medical Cannabis for Pain Relief?

CBD And Neuroplastic Mechanisms 

Understanding how CBD and BDNF interactions may support recovery involves looking at broader neuroplastic processes and the role of cannabinoids in brain health. 

CBD Neurotrophic Factors 

Some studies suggest CBD and neurotrophic factor interactions may enhance brain repair and resilience, potentially protecting against the structural damage linked to chronic depression. 

Cannabidiol and BDNF 

Evidence on cannabidiol and BDNF signalling shows CBD may increase BDNF expression in certain brain regions, improving adaptability and emotional regulation. 

CBD and Neuroplasticity 

The link between CBD and neuroplasticity and improved mood outcomes lies in its ability to strengthen neuronal connections, which could reduce vulnerability to relapse in mood-related conditions. 

In summary, early evidence on CBD and BDNF suggests CBD could play a role in enhancing neuroplasticity, but much more research is required before it becomes a mainstream therapeutic strategy. 

For patients interested in exploring CBD’s role in brain health, providers like LeafEase can offer professional consultations tailored to safe and evidence-based approaches. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Mood Disorders.

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories